NCT05495087

IHT for Mild Cognitive Impairment

Intermittent Hypoxia Training: A Novel Therapy for Mild Cognitive Impairment

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (estimated)
• Sponsor: University of North Texas Health Science Center · Academic / Other
• Sex: All
• Age: 55 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).

Conditions

• Mild Cognitive Impairment
• Memory Impairment

Interventions

Type	Name	Description
DEVICE	IHT Treatment	IHT Treatment: IH exposure to 10% O2 for up to 5 min, interspersed with breathing room air recovery for up to 5 min, with up to 8 cycles/session, 3 sessions/week, for up to 12 weeks.
OTHER	Sham-IHT Control	Sham-IHT Control: Exposure to 21% O2 for up to 5 min, interspersed with breathing room air recovery for up to 5 min, with up to 8 cycles/session, 3 sessions/week, for up to 12 weeks.

Timeline

• Start date: 2023-02-27
• Primary completion: 2025-04-30
• Completion: 2025-04-30
• First posted: 2022-08-10
• Last updated: 2023-04-06

Locations

1 site across 1 country: United States